These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography. Sakaguchi K, Jackson B, Chai SY, Mendelsohn FA, Johnson CI. J Cardiovasc Pharmacol; 1988 Dec; 12(6):710-7. PubMed ID: 2467090 [Abstract] [Full Text] [Related]
27. Hypertrophy induced alteration of action potential and effects of the inhibition of angiotensin converting enzyme by perindopril in infarcted rat hearts. Thollon C, Kreher P, Charlon V, Rossi A. Cardiovasc Res; 1989 Mar; 23(3):224-30. PubMed ID: 2531631 [Abstract] [Full Text] [Related]
28. Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction. Marie C, Mossiat C, Gros C, Schwartz JC, Lecomte JM, Bralet J. Cardiovasc Res; 1999 Mar; 41(3):544-53. PubMed ID: 10435026 [Abstract] [Full Text] [Related]
29. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Campbell DJ, Kladis A, Duncan AM. Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213 [Abstract] [Full Text] [Related]
30. Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme. Chai SY, Perich R, Jackson B, Mendelsohn FA, Johnston CI. Clin Exp Pharmacol Physiol Suppl; 1992 Apr; 19():7-12. PubMed ID: 1327597 [Abstract] [Full Text] [Related]
34. Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusion. van Wijngaarden J, Tobé TJ, Weersink EG, Bel KJ, de Graeff PA, de Langen CD, van Gilst WH, Wesseling H. J Cardiovasc Pharmacol; 1992 Mar; 19(3):408-16. PubMed ID: 1378122 [Abstract] [Full Text] [Related]
35. The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs. Tobé TJ, de Langen CD, Weersink EG, van Wijngaarden J, Bel KJ, de Graeff PA, van Gilst WH, Wesseling H. J Cardiovasc Pharmacol; 1992 May; 19(5):732-40. PubMed ID: 1381771 [Abstract] [Full Text] [Related]